Carisma Therapeutics Inc (CARM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -107,500 | -33,693 | -29,029 | 1,891 | -33,452 |
| Depreciation Amortization | 219 | 208 | 285 | 178 | 366 |
| Accounts payable and accrued liabilities | 535 | 460 | -760 | -742 | -1,212 |
| Other Working Capital | -3,097 | 578 | 611 | -2,557 | -976 |
| Other Operating Activity | 72,322 | 9,618 | 11,128 | 3,768 | 745 |
| Operating Cash Flow | $-37,521 | $-22,829 | $-17,765 | $2,538 | $-34,529 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -136 | -2 | 98 | 325 | -287 |
| Net Acquisitions | N/A | N/A | N/A | 136 | N/A |
| Investing Cash Flow | $-136 | $-2 | $98 | $461 | $-287 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 5,000 |
| Debt Repayment | N/A | N/A | N/A | -14,124 | -877 |
| Common Stock Issued | 35,356 | 58,583 | 7,005 | 304 | 12,713 |
| Financing Cash Flow | $35,356 | $58,583 | $7,005 | $-13,820 | $16,836 |
| Beginning Cash Position | 50,442 | 14,690 | 25,352 | 36,173 | 54,059 |
| End Cash Position | 48,141 | 50,442 | 14,690 | 25,352 | 36,079 |
| Net Cash Flow | $-2,301 | $35,752 | $-10,662 | $-10,821 | $-17,980 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,521 | -22,829 | -17,765 | 2,538 | -34,529 |
| Capital Expenditure | -136 | -2 | 98 | N/A | N/A |
| Free Cash Flow | -37,657 | -22,831 | -17,667 | 2,538 | -34,529 |